These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23732394)
1. Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death. Griveau A; Bejaud J; Anthiya S; Avril S; Autret D; Garcion E Int J Pharm; 2013 Oct; 454(2):765-74. PubMed ID: 23732394 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129 [TBL] [Abstract][Full Text] [Related]
3. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935 [TBL] [Abstract][Full Text] [Related]
4. Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells. Weyland M; Griveau A; Bejaud J; Benoit JP; Coursaget P; Garcion E Int J Pharm; 2013 Oct; 454(2):756-64. PubMed ID: 23769994 [TBL] [Abstract][Full Text] [Related]
5. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733 [TBL] [Abstract][Full Text] [Related]
6. Locoregional Confinement and Major Clinical Benefit of Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842 [TBL] [Abstract][Full Text] [Related]
7. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585 [TBL] [Abstract][Full Text] [Related]
8. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide. Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178 [TBL] [Abstract][Full Text] [Related]
9. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. Umerska A; Mouzouvi CR; Bigot A; Saulnier P Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999 [TBL] [Abstract][Full Text] [Related]
11. LNA-mediated microRNA silencing in non-human primates. Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051 [TBL] [Abstract][Full Text] [Related]
12. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304 [TBL] [Abstract][Full Text] [Related]
13. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells. Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292 [TBL] [Abstract][Full Text] [Related]
14. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187 [TBL] [Abstract][Full Text] [Related]
15. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro. Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841 [TBL] [Abstract][Full Text] [Related]
16. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505 [TBL] [Abstract][Full Text] [Related]
17. [Up-regulation of p27(kip1) by miR-221/222 antisense oligonucleotides enhances the radiosensitivity of U251 glioblastoma]. Zhang C; Wang G; Kang C; Du Y; Pu P Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):634-8. PubMed ID: 19953484 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the distribution, retention, and efficacy of internal radiation of Cikankowitz A; Clavreul A; Tétaud C; Lemaire L; Rousseau A; Lepareur N; Dabli D; Bouchet F; Garcion E; Menei P; Couturier O; Hindré F J Neurooncol; 2017 Jan; 131(1):49-58. PubMed ID: 27783195 [TBL] [Abstract][Full Text] [Related]
19. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115 [TBL] [Abstract][Full Text] [Related]
20. Surface active properties of lipid nanocapsules. Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]